AbbVie Inc. — Regulatory Filings 2014

Apr 25, 2014

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D. C. 20549*

*FORM 8-K*

*CURRENT REPORT*

*Pursuant to Section 13 or 15(d) of the*

*Securities Exchange Act of 1934*

Date of Report (Date of earliest event reported): April 25, 2014

*ABBVIE INC.*

(Exact name of registrant as specified in its charter)

Delaware	001-35565	32-0375147
(State or other Jurisdiction	(Commission File Number)	(IRS Employer
of Incorporation)		Identification No.)

*1 North Waukegan Road*

*North Chicago, Illinois 60064-6400*

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (847) 932-7900

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\C901710\14-10973-1\task6727941\10973-1-ba.htm',USER='C901710',CD='Apr 25 01:21 2014'

*Item 2.02. Results of Operations and Financial Condition*

On April 25, 2014, AbbVie Inc. issued a press release announcing its results of operations for the first quarter 2014. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

*Item 9.01 Financial Statements and Exhibits*

Exhibit No.	Exhibit
99.1	Press Release dated April 25, 2014 (furnished pursuant to Item 2.02).

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\C901710\14-10973-1\task6727941\10973-1-ba.htm',USER='C901710',CD='Apr 25 01:21 2014'

*SIGNATURE*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ABBVIE INC. — /s/ William J. Chase
William J. Chase
Executive Vice President,
Chief Financial Officer

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\C901710\14-10973-1\task6727941\10973-1-ba.htm',USER='C901710',CD='Apr 25 01:21 2014'

*EXHIBIT INDEX*

Exhibit No.	Exhibit
99.1	Press Release dated April 25, 2014 (furnished pursuant to Item 2.02).

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\C901710\14-10973-1\task6727941\10973-1-ba.htm',USER='C901710',CD='Apr 25 01:21 2014'